secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 76302 grounded facts newest September 1, 2026, 2:55 PM ET RSS · JSON

Showing 4801–4850 of 76302

Appointed

Alain Masse

President, North American Automotive
GPC · GENUINE PARTS CO
Effective
2025-08-01
Filed
June 9, 2025, 7:59 PM ET
the Board of Directors of the Company has appointed Alain Masse to the newly created position of President, North American Automotive, effective as of the Effective Date.
Appointed

Richard R. Barrera

Director
BTMD · biote Corp.
Effective
2025-06-05
Filed
June 9, 2025, 7:59 PM ET
On June 5, 2025, the Board of Directors (the “Board”) of biote Corp. (the “Company”), following the recommendation of the Nominating and Corporate Governance Committee, appointed Richard R. Barrera to serve as a member of the Board to fill the vacancy created by the prior resignation of Steven J. Heyer
Departed

Steven J. Heyer

Director
BTMD · biote Corp.
Successor
Richard R. Barrera
Filed
June 9, 2025, 7:59 PM ET
vacancy created by the prior resignation of Steven J. Heyer
Departed

Preston Grasty

Director
KLC · KinderCare Learning Companies, Inc.
Effective
2025-06-05
Filed
June 9, 2025, 7:59 PM ET
On June 5, 2025, Preston Grasty notified KinderCare Learning Companies, Inc. (the “Company”) that he would be resigning from the Company’s Board of Directors (the “Board”), effective immediately.
Appointed

Jason C. Murgio

Designated Director
GBLI · Global Indemnity Group, LLC
Effective
2025-06-04
Filed
June 9, 2025, 7:59 PM ET
Jason C. Murgio was appointed by the Class B Majority Shareholder (as defined below) to the Board to serve as a Designated Director (as defined below).
Departed

Jonathan A. Carnella

Director
NorthStar Healthcare Income, Inc.
Effective
2025-06-09
Filed
June 9, 2025, 7:59 PM ET
T. Andrew Smith, Jonathan A. Carnella, Gregory A. Samay and Kendall K. Young each resigned from the Company’s board of directors effective as of the Effective Time.
Departed

T. Andrew Smith

Director
NorthStar Healthcare Income, Inc.
Effective
2025-06-09
Filed
June 9, 2025, 7:59 PM ET
T. Andrew Smith, Jonathan A. Carnella, Gregory A. Samay and Kendall K. Young each resigned from the Company’s board of directors effective as of the Effective Time.
Departed

Nicholas R. Balzo

Chief Financial Officer and Treasurer
NorthStar Healthcare Income, Inc.
Effective
2025-06-09
Filed
June 9, 2025, 7:59 PM ET
the following officers resigned from the offices indicated besides such officers’ names and ceased to serve in such offices: Kendall K. Young Chief Executive Officer and President Nicholas R. Balzo Chief Financial Officer and Treasurer Ann B. Harrington General Counsel and Secretary
Departed

Ann B. Harrington

General Counsel and Secretary
NorthStar Healthcare Income, Inc.
Effective
2025-06-09
Filed
June 9, 2025, 7:59 PM ET
the following officers resigned from the offices indicated besides such officers’ names and ceased to serve in such offices: Kendall K. Young Chief Executive Officer and President Nicholas R. Balzo Chief Financial Officer and Treasurer Ann B. Harrington General Counsel and Secretary
Departed

Gregory A. Samay

Director
NorthStar Healthcare Income, Inc.
Effective
2025-06-09
Filed
June 9, 2025, 7:59 PM ET
T. Andrew Smith, Jonathan A. Carnella, Gregory A. Samay and Kendall K. Young each resigned from the Company’s board of directors effective as of the Effective Time.
Departed

Kendall K. Young

Director
NorthStar Healthcare Income, Inc.
Effective
2025-06-09
Filed
June 9, 2025, 7:59 PM ET
T. Andrew Smith, Jonathan A. Carnella, Gregory A. Samay and Kendall K. Young each resigned from the Company’s board of directors effective as of the Effective Time.
Departed

Kendall K. Young

Chief Executive Officer and President
NorthStar Healthcare Income, Inc.
Effective
2025-06-09
Filed
June 9, 2025, 7:59 PM ET
the following officers resigned from the offices indicated besides such officers’ names and ceased to serve in such offices: Kendall K. Young Chief Executive Officer and President Nicholas R. Balzo Chief Financial Officer and Treasurer Ann B. Harrington General Counsel and Secretary
Appointed

Christopher Donaghey

Director
AERG · APPLIED ENERGETICS, INC.
Effective
2025-06-03
Filed
June 9, 2025, 7:59 PM ET
On June 3, 2025, the Board of Directors of Applied Energetics expanded its number to seven members and appointed Christopher Donaghey and Scott Andrews to serve as new directors., effective immediately.
Appointed

Scott Andrews

Director
AERG · APPLIED ENERGETICS, INC.
Effective
2025-06-03
Filed
June 9, 2025, 7:59 PM ET
On June 3, 2025, the Board of Directors of Applied Energetics expanded its number to seven members and appointed Christopher Donaghey and Scott Andrews to serve as new directors., effective immediately.
Appointed

Saundra Pelletier

director
ADTX · Aditxt, Inc.
Effective
2025-06-05
Filed
June 9, 2025, 7:59 PM ET
On June 5, 2025, the Board of Directors (the “ Board ”) of the Company, with the recommendation of the Nominating and Corporate Governance Committee, appointed Ms. Saundra Pelletier as a member of the Board.
Appointed

Matthew C. Cassell

Chief Revenue Officer
MYFW · First Western Financial Inc
Effective
2025-06-05
Filed
June 9, 2025, 7:59 PM ET
On and effective June 5, 2025, the Board of Directors of First Western Financial, Inc. (the “Company”) appointed Matthew C. Cassell to serve as Chief Revenue Officer of First Western Trust Bank (the “Bank”).
Departed

Gordon M. Burns

Director
Compass Group Diversified Holdings LLC
Effective
2025-06-07
Filed
June 9, 2025, 7:59 PM ET
on June 7, 2025, Mr. Burns notified the Trust and the Board of his intent to resign as a director of the Company, effective June 7, 2025.
Appointed

Raffiq Nathoo

independent director
AWK · American Water Works Company, Inc.
Effective
2025-06-09
Filed
June 9, 2025, 7:59 PM ET
the Board appointed Raffiq Nathoo as an independent director, effective immediately
Departed

Daniel S. Devorsetz

Chief Investment Officer
HRZN · Horizon Technology Finance Corp
Effective
2025-06-05
Successor
Paul G. Seitz
Filed
June 9, 2025, 7:59 PM ET
On June 5, 2025, Daniel S. Devorsetz stepped down as Chief Investment Officer and Chief Operating Officer of Horizon Technology Finance Corporation (the “ Company ”.
Appointed

Paul G. Seitz

Chief Investment Officer
HRZN · Horizon Technology Finance Corp
Effective
2025-06-05
Filed
June 9, 2025, 7:59 PM ET
On June 5, 2025, the Board of Directors of the Company unanimously elected Paul G. Seitz, 38, as Chief Investment Officer.
Departed

Daniel S. Devorsetz

Chief Operating Officer
HRZN · Horizon Technology Finance Corp
Effective
2025-06-05
Filed
June 9, 2025, 7:59 PM ET
On June 5, 2025, Daniel S. Devorsetz stepped down as Chief Investment Officer and Chief Operating Officer of Horizon Technology Finance Corporation (the “ Company ”.
Appointed

Raymond Kelly

Director
ESQ · Esquire Financial Holdings, Inc.
Effective
2025-06-06
Filed
June 9, 2025, 7:59 PM ET
Raymond Kelly has been appointed to the Board of Directors of the Company and the Bank, effective June 6, 2025.
Appointed

Jason D. Davis

Chief Financial Officer
FBLG · FibroBiologics, Inc.
Effective
2025-06-09
Filed
June 9, 2025, 7:59 PM ET
On June 9, 2025, FibroBiologics, Inc. (the “Company”) announced that Jason D. Davis has been appointed as the Company’s Chief Financial Officer, effective as of June 9, 2025 (the “Effective Date”).
Appointed (interim)

Kaouthar Lbiati

Interim Chief Executive Officer
HEPA · Hepion Pharmaceuticals, Inc.
Effective
2025-06-16
Filed
June 9, 2025, 7:59 PM ET
On June 3, 2025, the Board of Directors of Hepion Pharmaceuticals, Inc., a Delaware corporation (the “ Company ”), approved the appointment of Dr. Kaouthar Lbiati, a director of the Company, as interim Chief Executive Officer, effective June 16, 2025.
Appointed

Yi Yang

Director
IPW · iPower Inc.
Effective
2025-06-05
Filed
June 9, 2025, 7:59 PM ET
appointed a new director, Yi Yang, to the Board, effective June 5, 2025.
Appointed

Michael W. Sumruld

Senior Vice President of Finance
OII · OCEANEERING INTERNATIONAL INC
Effective
2025-09-01
Filed
June 6, 2025, 7:59 PM ET
Mr. Michael W. Sumruld will join the Company as Senior Vice President of Finance on September 1, 2025, and is expected to succeed Mr. Curtis as Chief Financial Officer upon Mr. Curtis’s retirement from such position.
Departed

Thomas J. Snyder

President of Silgan Containers
SLGN · SILGAN HOLDINGS INC
Effective
2025-06-04
Filed
June 6, 2025, 7:59 PM ET
On June 3, 2025, Thomas J. Snyder, President of Silgan Containers, the U.S. metal container operations of Silgan Holdings Inc., or the Company, notified the Company that he was resigning from his position with Silgan Containers to pursue another opportunity.
Appointed

Steven F. Mayer

Director
ARAY · ACCURAY INC
Effective
2025-06-03
Filed
June 6, 2025, 7:59 PM ET
On June 3, 2025, the Board appointed Steven F. Mayer to the Board as a Class III director, with a term expiring at the Company’s 2027 annual meeting of stockholders, effective immediately prior to, and contingent upon, the effectiveness of the Financing Agreement.
Departed

Carl L. Gordon

Director
MBX · MBX Biosciences, Inc.
Effective
2025-06-05
Filed
June 6, 2025, 7:59 PM ET
Also effective as of June 5, 2025 was the departure of Carl L. Gordon, Ph.D., CFA from the Company's board of directors.
Appointed

Maha Radhakrishnan, M.D.

Director
CADL · Candel Therapeutics, Inc.
Effective
2025-06-04
Filed
June 6, 2025, 7:59 PM ET
On June 4, 2025, the Board of Directors (the “Board”) of Candel Therapeutics, Inc. (the “Company”) increased the size of the Board from nine (9) to ten (10) directors and unanimously appointed Maha Radhakrishnan, M.D., to fill the newly created vacancy on the Board, effective June 4, 2025.
Departed

David Shook

Chief Medical Officer and Head of Research & Development
NKTX · Nkarta, Inc.
Effective
2025-06-06
Successor
Shawn Rose, M.D. Ph.D.
Filed
June 6, 2025, 7:59 PM ET
David Shook, M.D. notified Nkarta, Inc. (the “Company”) of his decision to resign as Chief Medical Officer and Head of Research & Development of the Company to pursue other opportunities in the oncology space.
Appointed

Shawn Rose

Chief Medical Officer and Head of Research and Development
NKTX · Nkarta, Inc.
Effective
2025-06-23
Filed
June 6, 2025, 7:59 PM ET
Shawn Rose, M.D. Ph.D. has been appointed by the Company to succeed Dr. Shook as Chief Medical Officer and Head of Research and Development starting on June 23, 2025.
Departed

Shahram Ghasemian

Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
LEU · CENTRUS ENERGY CORP
Effective
2025-06-29
Successor
Richard Emery
Filed
June 6, 2025, 7:59 PM ET
On June 5, 2025, Mr. Shahram Ghasemian, Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary of Centrus Energy Corp. (the “Company”) provided notice that he will resign from his positions at the Company, effective June 29, 2025, in order to pursue another opportunity.
Appointed (interim)

Richard Emery

Acting General Counsel, Chief Compliance Officer & Corporate Secretary
LEU · CENTRUS ENERGY CORP
Effective
2025-06-29
Filed
June 6, 2025, 7:59 PM ET
Effective upon Mr. Ghasemian's departure, Mr. Richard Emery will be appointed as Acting General Counsel, Chief Compliance Officer & Corporate Secretary of the Company.
Departed

Kurt Darrow

Director
CMS-PB · CONSUMERS ENERGY CO
Effective
2025-07-01
Filed
June 6, 2025, 7:59 PM ET
On June 5, 2025, Kurt Darrow, who has served as a member of the CMS Energy Corporation (“CMS Energy”) and Consumers Energy Company (“Consumers”) Boards of Directors (“Boards”) since 2013, informed CMS Energy and Consumers that he has decided to retire from the Boards, effective July 1, 2025.
Appointed

Chen Yi (Jean) Hsu

trustee
Antares Strategic Credit Fund
Effective
2025-06-02
Filed
June 6, 2025, 7:59 PM ET
Effective as of June 2, 2025, Chen Yi (Jean) Hsu was appointed by the Board of Trustees (the “ Board ”) of Antares Strategic Credit Fund (the “ Company ”) as a trustee.
Appointed

Chen Yi (Jean) Hsu

trustee
Antares Private Credit Fund
Effective
2025-06-02
Filed
June 6, 2025, 7:59 PM ET
Effective as of June 2, 2025, Chen Yi (Jean) Hsu was appointed by the Board of Trustees (the “ Board ”) of Antares Private Credit Fund (the “ Company ”) as a trustee.
Departed

Brent Rhodes

Chief Accounting Officer
HUBG · Hub Group, Inc.
Effective
2025-06-27
Successor
Dennis Mathews
Filed
June 6, 2025, 7:59 PM ET
On June 2, 2025, Brent Rhodes notified Hub Group, Inc. (the "Company") of his decision to resign from the position of Chief Accounting Officer effective June 27, 2025 ("Effective Date").
Appointed

Dennis Mathews

Chief Accounting Officer
HUBG · Hub Group, Inc.
Effective
2025-06-30
Filed
June 6, 2025, 7:59 PM ET
On June 6, 2025, Dennis Mathews was appointed as the Company's Chief Accounting Officer effective June 30, 2025.
Appointed

Conor Hanley

Director
KMTS · KESTRA MEDICAL TECHNOLOGIES, LTD.
Effective
2025-06-04
Filed
June 6, 2025, 7:59 PM ET
On June 4, 2025, the Board of Directors (the “Board”) of Kestra Medical Technologies, Ltd. (the “Company”) elected Mr. Conor Hanley as a new member of the Board.
Departed

Tralisa Maraj

Chief Financial Officer
LVWR · LiveWire Group, Inc.
Effective
2025-07-11
Filed
June 6, 2025, 7:59 PM ET
On June 6, 2025, Tralisa Maraj, the Chief Financial Officer of LiveWire Group, Inc. (the “Company”), announced her resignation effective July 11, 2025 allowing sufficient time for a transition of her responsibilities before pursuing another opportunity outside the Company.
Departed

Courtney Conigliaro

Chief Financial Officer
OACC · Oaktree Acquisition Corp. III Life Sciences
Effective
2025-06-03
Successor
Thomas Sweeney
Filed
June 6, 2025, 7:59 PM ET
On June 3, 2025, Courtney Conigliaro notified the board of directors (the "Board") of Oaktree Acquisition Corp. III Life Sciences (the "Company") of her resignation as Chief Financial Officer of the Company.
Appointed

Thomas Sweeney

Chief Financial Officer
OACC · Oaktree Acquisition Corp. III Life Sciences
Effective
2025-06-03
Filed
June 6, 2025, 7:59 PM ET
On June 3, 2025, the Board appointed Thomas Sweeney as new Chief Financial Officer (principal accounting and principal financial officer) of the Company, effective immediately.
Role change

Jay C. Horgen

Chief Executive Officer
AMG · AFFILIATED MANAGERS GROUP, INC.
Effective
2025-06-03
Filed
June 6, 2025, 7:59 PM ET
Jay C. Horgen, previously President and Chief Executive Officer, will continue as Chief Executive Officer of the Company.
Role change

Thomas M. Wojcik

President and Chief Operating Officer
AMG · AFFILIATED MANAGERS GROUP, INC.
Effective
2025-06-03
Filed
June 6, 2025, 7:59 PM ET
On June 3, 2025, Thomas M. Wojcik was appointed President of Affiliated Managers Group, Inc. (the “Company”).
Departed

Dr. Marvin S. Hausman

Director
LUDG · LUDWIG ENTERPRISES, INC.
Effective
2025-06-05
Filed
June 6, 2025, 7:59 PM ET
On June 5, 2025, the Board of Directors (the “Board”) of Ludwig Enterprises, Inc. (the “Company”) received a letter of resignation from Dr. Marvin S. Hausman from his position on the Board, Dr. Hausman will remain in his position as Chief Scientific Officer of the Company.
Appointed

Samir Elias Hachem Kerbage

Director of the Sponsor
NCIQ · Hashdex Nasdaq CME Crypto Index ETF
Effective
2025-06-02
Filed
June 6, 2025, 7:59 PM ET
Effective June 2, 2025, Samir Elias Hachem Kerbage was appointed to the Board of Directors of the Sponsor.
Departed

Bruno Leonardo Kmita de Oliveira Passos

Director of the Sponsor
NCIQ · Hashdex Nasdaq CME Crypto Index ETF
Effective
2025-06-02
Successor
Samir Elias Hachem Kerbage
Filed
June 6, 2025, 7:59 PM ET
On June 2, 2025, Bruno Leonardo Kmita de Oliveira Passos resigned from his role as a member of the Board of Directors of Hashdex Asset Management Ltd. (the “Sponsor”), the sponsor of the Hashdex Nasdaq Crypto Index US ETF (the “Trust”).
Appointed (interim)

Natalie Russell

Interim Chief Financial Officer
CYN · Cyngn Inc.
Effective
2025-06-06
Filed
June 6, 2025, 7:59 PM ET
As previously disclosed, effective June 6, 2025, Natalie Russell, the Company’s Director of Accounting, will serve as the Company’s Interim Chief Financial Officer.
Departed

Donald Alvarez

Chief Financial Officer
CYN · Cyngn Inc.
Effective
2025-06-06
Successor
Natalie Russell
Filed
June 6, 2025, 7:59 PM ET
Effective June 6, 2025, Donald Alvarez stepped down as a member of the board of directors (the “Board”) and Chief Financial Officer of Cyngn Inc. (the “Company”).

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.